Tracers / [64Cu]Cu-FAPI-2286

[64Cu]Cu-FAPI-2286

Also written as [64Cu]Cu-FAPI-2286; [Cu-64]Cu-FAPI-2286

Radionuclide: Cu-64 t½ 762 min
Modality: PET
Production route: —
Stage: —
Syntheses indexed: 2

What it is

Compound class: —
Target / mechanism: —
Clinical application: —
Theranostic pair: <a href="/tracers/lu177-fapi2286/">lu177-fapi2286</a>

Regulatory status

FDA: —
EMA (centralised): —
Other approvals: —
Brand names: —

Clinical use

Typical injected activity: —
Uptake time: —

Reported in the literature. Not a dosing recommendation.

Published syntheses

Module	Cassette	Purification	Yield %	RCP %	Precursor / supplier	Source
—	—	—	—	—	—	41599688 2026 Pharmaceuticals (Basel)
—	—	—	—	>95%	FAPI-2286	42425054 2026 Nucl Med Biol

Need this precursor?We can point you to suppliers for [64Cu]Cu-FAPI-2286, or handle the enquiry for you.

Get in touch

Quality control Preliminary — inferred from compound class

Ph. Eur. monograph: —
USP monograph: —

AppearancepHRCP HPLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrityMolar activityMetal impurities

How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); radiometal tracer -> metal impurities (rule); receptor ligand with a saturable target -> molar activity (rule)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [64Cu]Cu-FAPI-2286.

Get in touch

Notes

Added from reverse module search (stage 6); 1 article(s) with Cu-64. Also seen with Cu-67[1], Ga-68[1], Lu-177[1] (too few articles for own row).